SLE patients showed a significantly lower percentage of EPCs CD133+ (p = 0.027) and particularly of EPCs CD133+VEGFR2+ (p = 0.012) when compared to HCs (Figure 2B) (Supplemental Table 1). This evidence concerns the gene PROM1 and systemic lupus erythematosus.